Brown, Lisle/Cummings, Inc. Moderna, Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 1,635 shares of MRNA stock, worth $88,878. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,635
Previous 1,535
6.51%
Holding current value
$88,878
Previous $182 Million
40.06%
% of portfolio
0.03%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,048Shares Held
242MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.36 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.15 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.39 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$817 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$393 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $21.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...